CBD and Seizures: New Clinical Evidence Challenges Common Beliefs Introduction CBD and seizures research has skyrocketed in recent years, challenging traditional treatment paradigms for refractory epilepsy. Epilepsy affects approximately 50 million people globally, according to the World Health Organization (WHO). This neurological disorder, previously limited
Neurology
Can MRI Detect Old Strokes? New Findings on Silent Brain Infarcts
Can MRI Detect Old Strokes? New Findings on Silent Brain Infarcts Introduction The question of whether an old stroke appears on magnetic resonance imaging (MRI) holds remarkable clinical importance, particularly in the context of silent brain infarcts (SBIs). These lesions, often asymptomatic, are increasingly recognized as markers
Neuromodulation for Chronic Pain: Breaking Traditional Treatment Boundaries
Neuromodulation for Chronic Pain: Breaking Traditional Treatment Boundaries Introduction Epilepsy affects more than 70 million individuals worldwide, and approximately 30 percent of patients experience resistance to conventional medical therapy. This subset of patients with drug-resistant or intractable epilepsy often faces major challenges, including reduced quality of
Are We Over-Scanning? The Truth About CT Scans in Minor Head Injury Cases
Are We Over-Scanning? The Truth About CT Scans in Minor Head Injury Cases Introduction Computed tomography (CT) has become an essential tool in the evaluation of head injuries in emergency departments across the world. Its speed and accuracy in detecting intracranial hemorrhage, skull fractures, and other
Post Surgery Brain Fog: New Evidence Questions Long-Term Safety of Anesthesia
Post Surgery Brain Fog: New Evidence Questions Long-Term Safety of Anesthesia Introduction Post-surgical brain fog represents a significant and under-recognized complication of anesthesia and surgery, affecting a substantial proportion of patients. Perioperative neurocognitive disorders (PND), which encompass postoperative delirium and longer-term cognitive decline, are
New Alzheimer’s Treatment Targets
Beyond Amyloid: New Alzheimer's Treatment Targets Alternative Brain Pathways Introduction Alzheimer's disease, the most common cause of dementia accounting for 60-70% of all cases, requires new Alzheimer's treatment approaches as current strategies show limited efficacy. According to the World Health Organization's 2022 blueprint for
How Diet and Exercises Prevent Dementia Through Gut-Brain Pathways
Biomarkers for Alzheimer’s Disease: PET to Plasma
Biomarkers for Alzheimer’s Disease: PET to Plasma Abstract Background:The diagnostic landscape of Alzheimer’s disease (AD) has shifted considerably in recent years. Traditional diagnosis relied heavily on clinical assessments supported by neuropsychological testing and structural imaging. These approaches, while valuable, often lacked the sensitivity and specificity needed to
Ketogenic Diets in Neurology and Endocrinology: Friend or Fad?
Ketogenic Diets in Neurology and Endocrinology: Friend or Fad? Abstract The ketogenic diet (KD), defined by a high fat, moderate protein, and very low carbohydrate composition, has undergone a notable resurgence in both clinical practice and popular health discourse. Initially introduced in the 1920s as
Neurocysticercosis: The Hidden Brain Parasite Crossing Global Borders in 2025
Neurocysticercosis: The Hidden Brain Parasite Crossing Global Borders in 2025 Introduction Neurocysticercosis remains the most prevalent parasitic infection of the human central nervous system (CNS) and continues to represent a major global health challenge. Current estimates suggest that more than 50 million individuals
